BioMarin Enzymes Inc.

Merck Serono Initiates KAMPER, the First Pan-European Registry for Patients Under Kuvan(R) Therapy.
PR Newswire Europe; 12/10/2009; 1477 words; ...by a deficiency of the enzyme phenylalanine hydroxylase...foods. If the active enzyme is not present in sufficient...of the five different enzymes involved in BH4 synthesis...Developed by Merck Serono and BioMarin Pharmaceutical Inc. (Nasdaq and SWX...a naturally occurring enzyme ...

Premarket roundup: Men's Wearhouse, Cisco
AP Online; 12/9/2009; 554 words; ...Modoff said Cisco Systems Inc.'s meeting with analysts...marketplace Liquidity Services Inc., said Oppenheimer analyst...strong gains for shares of BioMarin Pharmaceutical Inc. after the company reports...intended to treat a rare enzyme disease, and upgraded...

Ahead of the Bell: BioMarin Pharma upgraded
AP Online; 12/9/2009; 604 words; ...gains for shares of BioMarin Pharmaceutical Inc. after the company...intended to treat a rare enzyme disease, and upgraded...Salveen Kochnover expects BioMarin to report positive data...GALNS data should boost BioMarin's shares. She set...

Merck Serono Launches New Website on Phenylketonuria.(Website overview)
PR Newswire Europe; 11/25/2009; 1553 words; ...a deficiency of the enzyme phenylalanine hydroxylase...foods. If the active enzyme is not present in sufficient...by Merck Serono and BioMarin Pharmaceutical Inc. (Nasdaq and SWX...of the agreement with BioMarin, Merck Serono has exclusive...

Particles Detected in Vials from Genzyme's Plant Not Expected to Impact Aldurazyme or Naglazyme.
Biotech Week; 11/25/2009; 665 words; BioMarin Pharmaceutical Inc. (NASDAQ:BMRN...treating patients with enzyme replacement products...administration (see also BioMarin Pharmaceutical Inc.). For Aldurazyme...drug. Accordingly, BioMarin does not expect this...